Bicycle Therapeutics (BCYC) Receivables - Other (2019 - 2026)

Bicycle Therapeutics' Receivables - Other history runs 8 years deep, the most recent figure standing at $40.9 million for Q1 2026.

• Quarterly Receivables - Other fell 11.54% year-over-year to $40.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $40.9 million (down 11.54% YoY) and the FY2025 annual result came in at $35.6 million, changed 0.28% from the prior year.
• Receivables - Other was $40.9 million for Q1 2026 at Bicycle Therapeutics, up from $35.6 million in the prior quarter.
• Across five years, Receivables - Other topped out at $67.3 million in Q3 2025 and bottomed at $11.4 million in Q3 2022.
• A 5-year average of $33.6 million and a median of $35.6 million in 2025 frame the typical range for Receivables - Other.
• Annual changes were most pronounced in 2023 — Receivables - Other slipped 20.81% — and 2024, when it jumped 260.47%.
• Bicycle Therapeutics' Receivables - Other stood at $19.2 million in 2022, then increased by 25.45% to $24.0 million in 2023, then soared by 48.51% to $35.7 million in 2024, then retreated by 0.28% to $35.6 million in 2025, then advanced by 14.89% to $40.9 million in 2026.
• Business Quant data shows BCYC's Receivables - Other at $40.9 million in Q1 2026, $35.6 million in Q4 2025, and $67.3 million in Q3 2025.